New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Nancy Kartiko, MD
Advertisement
Dr Kartiko is a third-year psychiatry resident at Creighton University.
Articles by Nancy Kartiko, MD
Advertisement
Latest Updated Articles
Benzodiazepine Discontinuation Associated With Increased Mortality in Patients on Stable, Long-Term BenzodiazepinesPublished: April 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder
2
The Spiritual Determinants of Health and Mental Health
3
Caplyta FDA Approval: Benefits for Patients, With Roger McIntyre, MD
4
Bridging the Categorical-Dimensional Divide: Exploring the PRiSM Diagnostic Instrument
5
